Conexeu holder owns 4.31M shares, 9.99% stake

Rhea-AI Filing Summary

Conexeu Sciences Inc. (CNXU) received an amended Schedule 13G showing that Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund reports beneficial ownership of 4,314,336 common shares, representing up to 9.99% of the company’s common shares as of June 30, 2026.

The reported position includes 2,200,000 common share warrants, which may not be exercised if doing so would cause the holder to exceed 9.99% of Conexeu Sciences Inc.’s outstanding common shares on the exercise date. The reporting person has sole voting and dispositive power over the reported securities.

Key Figures

Beneficially owned common shares: 4,314,336 shares Percent of class: 9.99% Common share warrants included: 2,200,000 warrants +2 more

5 metrics

Beneficially owned common shares 4,314,336 shares Beneficial ownership of Conexeu Sciences Inc. common shares as reported in the Schedule 13G/A

Percent of class 9.99% Reported percentage of Conexeu Sciences Inc. common shares beneficially owned

Common share warrants included 2,200,000 warrants Warrants included in beneficial ownership, subject to a 9.99% ownership blocker on exercise

Sole voting power 4,314,336 shares Shares over which the reporting person has sole power to vote or direct the vote

Sole dispositive power 4,314,336 shares Shares over which the reporting person has sole power to dispose or direct the disposition

Key Terms

beneficially owned, Sole Voting Power, Sole Dispositive Power, Percent of class, +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: 4,314,336 Includes 2,200,000 common shares warrants"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"5 | Sole Voting Power 4,314,336.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"7 | Sole Dispositive Power 4,314,336.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Percent of class financial

"Percent of class: Up to 9.99%"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

common shares warrants financial

"Includes 2,200,000 common shares warrants which may not be exercised"

FAQ

What ownership stake in CNXU does Multi-Valor AIF Umbrella Fund report in this Schedule 13G/A?

Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund reports beneficial ownership of 4,314,336 common shares of Conexeu Sciences Inc., representing up to 9.99% of the company’s outstanding common shares as of June 30, 2026.

How many CNXU common share warrants are included in the reported holdings?

The reported beneficial ownership includes 2,200,000 common share warrants. These warrants are subject to a condition that they may not be exercised if such exercise would cause the holder to own more than 9.99% of Conexeu Sciences Inc.’s outstanding common shares on the exercise date.

Does the reporting person have sole voting power over its CNXU shares?

Yes. The filing states the reporting person has sole voting power over 4,314,336 common shares and no shared voting power in Conexeu Sciences Inc.

What dispositive power over CNXU shares does the fund report?

The reporting person has sole dispositive power over 4,314,336 common shares of Conexeu Sciences Inc. and reports no shared dispositive power.

Who signed the Schedule 13G/A for CNXU on behalf of the reporting person?

The Schedule 13G/A was signed by Robert Sven Soroer as Director of the reporting person on September 4, 2026.

What is the citizenship or place of organization of the CNXU reporting person?

The reporting person, Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund, is organized in Liechtenstein, which is also listed as its citizenship in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 12:01 PM Accepted by SEC EDGAR 09/04/2026 - 12:00 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Conexeu Sciences Inc.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

LIECHTENSTEIN

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,314,336.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,314,336.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,314,336.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Includes 2,200,000 common shares warrants which may not be exercised by the Reporting Person if such exercise would result in the Reporting Person holding over 9.99% of the Issuer's outstanding common shares on the date of exercise.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Conexeu Sciences Inc.
(b)	Address of issuer's principal executive offices: 50 West Liberty Street, Sutie 880, Reno, NV 89501
Item 2.
(a)	Name of person filing: Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund ("Reporting Person")
(b)	Address or principal business office or, if none, residence: c/o VP Fund Solutions (Liechtenstein) AG Aeulestrasse 6 Vaduz 9490 Principal of Liechtenstein
(c)	Citizenship: Liechtenstein
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,314,336 Includes 2,200,000 common shares warrants which may not be exercised by the Reporting Person if such exercise would result in the Reporting Person holding over 9.99% of the Issuer's outstanding common shares on the date of exercise.
(b)	Percent of class: Up to 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4,314,336
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 4,314,336
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund

Signature:	/s/ Robert Sven Soroer
Name/Title:	Director
Date:	09/04/2026